1. Home
  2. MDAIW vs ORA Comparison

MDAIW vs ORA Comparison

Compare MDAIW & ORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAIW
  • ORA
  • Stock Information
  • Founded
  • MDAIW N/A
  • ORA 1965
  • Country
  • MDAIW United States
  • ORA United States
  • Employees
  • MDAIW 78
  • ORA N/A
  • Industry
  • MDAIW Medical/Dental Instruments
  • ORA Electric Utilities: Central
  • Sector
  • MDAIW Health Care
  • ORA Utilities
  • Exchange
  • MDAIW Nasdaq
  • ORA Nasdaq
  • Market Cap
  • MDAIW N/A
  • ORA N/A
  • IPO Year
  • MDAIW 2021
  • ORA 2004
  • Fundamental
  • Price
  • MDAIW $0.47
  • ORA $67.52
  • Analyst Decision
  • MDAIW
  • ORA Buy
  • Analyst Count
  • MDAIW 0
  • ORA 6
  • Target Price
  • MDAIW N/A
  • ORA $85.33
  • AVG Volume (30 Days)
  • MDAIW N/A
  • ORA 782.0K
  • Earning Date
  • MDAIW N/A
  • ORA 02-19-2025
  • Dividend Yield
  • MDAIW N/A
  • ORA 0.71%
  • EPS Growth
  • MDAIW N/A
  • ORA 7.82
  • EPS
  • MDAIW N/A
  • ORA 1.96
  • Revenue
  • MDAIW N/A
  • ORA $890,253,000.00
  • Revenue This Year
  • MDAIW N/A
  • ORA $7.80
  • Revenue Next Year
  • MDAIW N/A
  • ORA $10.64
  • P/E Ratio
  • MDAIW N/A
  • ORA $34.48
  • Revenue Growth
  • MDAIW N/A
  • ORA 12.18
  • 52 Week Low
  • MDAIW N/A
  • ORA $59.41
  • 52 Week High
  • MDAIW N/A
  • ORA $84.30
  • Technical
  • Relative Strength Index (RSI)
  • MDAIW N/A
  • ORA 24.01
  • Support Level
  • MDAIW N/A
  • ORA $71.77
  • Resistance Level
  • MDAIW N/A
  • ORA $74.86
  • Average True Range (ATR)
  • MDAIW 0.00
  • ORA 2.19
  • MACD
  • MDAIW 0.00
  • ORA -1.34
  • Stochastic Oscillator
  • MDAIW 0.00
  • ORA 7.71

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: